{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:20:37Z","timestamp":1794406837518,"version":"4.9.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patient-reported outcome measures (PROMs) are recommended for assessing patient-centered outcomes in inflammatory bowel disease (IBD). The main aims were to assess the level of participation in an electronic PROM (ePROM) data collection system among patients with IBD, and evaluate reliability and validity of the resulting scores.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients included in the IBD registry of Maccabi Healthcare Services, a state-mandated healthcare provider for over 2.6 million people in Israel, were invited to complete the IBD-Control measure and a general health item, with follow-up ePROMs at 3 and 6\u00a0months including a global rating of change item. Descriptive statistics were used to compare patient characteristics by participation rate, and assess survey completion time. Initial scores were assessed for internal consistency reliability using Cronbach's alpha. Test\u2013retest reliability was assessed using the intraclass correlation coefficient from paired scores of patients identified as unchanged between the initial and first follow-up. Construct validity was assessed by the ability of IBD-control scores to discriminate between patient sub-groups in expected ways. Empirical validity was assessed using ePROM score correlations with laboratory markers of disease activity. Score coverage was also assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 13,588 patients were invited to participate [Mean age\u2009=\u200949\u00a0years (SD\u2009=\u200917); females\u2009=\u200951%]. Participation rate was 31.5%. Participants compared to non-participants were slightly older, were more likely to be female, to have a history of biologic treatment, to have higher socio-economic status, and to be more experienced in the usage of the digital patient portal. Median survey completion time was approximately 1:30\u00a0min. Internal consistency and test\u2013retest reliability were 0.86 and 0.98, respectively. Scores discriminated between patient sub-groups in clinically expected ways, with expected correlations to laboratory markers of disease activity. A notable ceiling effect was observed (&gt;\u200915%) for IBD-Control scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Feasibility, reliability, and validity of the ePROM system was supported for measuring the level of perceived disease control in patients diagnosed with IBD in Israel. Additional research is needed to identify ways to increase patient participation, assess clinical implications of the identified measurement ceiling of the IBD-control, and evaluate the added value of the derived scores in support of clinical decision making.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12955-023-02087-0","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T12:05:03Z","timestamp":1673611503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Implementing electronic patient reported outcomes in inflammatory bowel disease: patient participation, score reliability and validity"],"prefix":"10.1186","volume":"21","author":[{"given":"Daniel","family":"Deutscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Chodick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sveta","family":"Tsukinovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Bodger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Waterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revital","family":"Kariv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"2087_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jclinepi.2017.04.014","volume":"89","author":"CO Bingham 3rd","year":"2017","unstructured":"Bingham CO 3rd, Noonan VK, Auger C, Feldman DE, Ahmed S, Bartlett SJ. Montreal Accord on Patient-Reported Outcomes (PROs) use series\u2014Paper 4: patient-reported outcomes can inform clinical decision making in chronic care. J Clin Epidemiol. 2017;89:136\u201341.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2087_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2217\/cer-2015-0014","volume":"5","author":"I Porter","year":"2016","unstructured":"Porter I, Goncalves-Bradley D, Ricci-Cabello I, Gibbons C, Gangannagaripalli J, Fitzpatrick R, et al. Framework and guidance for implementing patient-reported outcomes in clinical practice: evidence, challenges and opportunities. J Comp Eff Res. 2016;5(5):507\u201319.","journal-title":"J Comp Eff Res"},{"key":"2087_CR3","doi-asserted-by":"crossref","unstructured":"Bojic D, Bodger K, Travis S. Patient Reported Outcome Measures (PROMs) in inflammatory bowel disease: new data. J Crohns Colitis. 2017;11(suppl_2):S576\u2013S85.","DOI":"10.1093\/ecco-jcc\/jjw187"},{"issue":"2","key":"2087_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/00365521.2020.1857430","volume":"56","author":"ME de Jong","year":"2021","unstructured":"de Jong ME, Taal E, Thomas PWA, Romkens TEH, Jansen JM, West RL, et al. Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease. Scand J Gastroenterol. 2021;56(2):155\u201361.","journal-title":"Scand J Gastroenterol"},{"key":"2087_CR5","doi-asserted-by":"crossref","unstructured":"de Jong MJ, Huibregtse R, Masclee AAM, Jonkers D, Pierik MJ. Patient-reported outcome measures for use in clinical trials and clinical practice in inflammatory bowel diseases: a systematic review. Clin Gastroenterol Hepatol. 2018;16(5):648\u201363 e3.","DOI":"10.1016\/j.cgh.2017.10.019"},{"issue":"7","key":"2087_CR6","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1136\/gutjnl-2013-305600","volume":"63","author":"K Bodger","year":"2014","unstructured":"Bodger K, Ormerod C, Shackcloth D, Harrison M, Collaborative IBDC. Development and validation of a rapid, generic measure of disease control from the patient\u2019s perspective: the IBD-control questionnaire. Gut. 2014;63(7):1092\u2013102.","journal-title":"Gut"},{"key":"2087_CR7","doi-asserted-by":"crossref","unstructured":"Cheung WY, Garratt AM, Russell IT, Williams JG. The UK IBDQ-a British version of the inflammatory bowel disease questionnaire. development and validation. J Clin Epidemiol 2000;53(3):297\u2013306.","DOI":"10.1016\/S0895-4356(99)00152-3"},{"issue":"3","key":"2087_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"G EuroQol","year":"1990","unstructured":"EuroQol G. EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy (Amsterdam, Netherlands). 1990;16(3):199\u2013208.","journal-title":"Health Policy (Amsterdam, Netherlands)"},{"issue":"4","key":"2087_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/ecco-jcc\/jjx161","volume":"12","author":"AH Kim","year":"2018","unstructured":"Kim AH, Roberts C, Feagan BG, Banerjee R, Bemelman W, Bodger K, et al. Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease-an International, Cross-disciplinary consensus. J Crohns Colitis. 2018;12(4):408\u201318.","journal-title":"J Crohns Colitis"},{"key":"2087_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40814-018-0282-8","volume":"4","author":"S O'Connell","year":"2018","unstructured":"O\u2019Connell S, Palmer R, Withers K, Saha N, Puntoni S, Carolan-Rees G, et al. Requirements for the collection of electronic PROMS either \u201cin clinic\u201d or \u201cat home\u201d as part of the PROMs, PREMs and Effectiveness Programme (PPEP) in Wales: a feasibility study using a generic PROM tool. Pilot Feasibility Stud. 2018;4:90.","journal-title":"Pilot Feasibility Stud"},{"key":"2087_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2147\/CLEP.S151339","volume":"10","author":"MY Friedman","year":"2018","unstructured":"Friedman MY, Leventer-Roberts M, Rosenblum J, Zigman N, Goren I, Mourad V, et al. Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study. Clin Epidemiol. 2018;10:671\u201381.","journal-title":"Clin Epidemiol"},{"issue":"10","key":"2087_CR12","first-page":"655","volume":"157","author":"R Kariv","year":"2018","unstructured":"Kariv R, Turner D, Rosenblum J, Morad V, Zigman N, Friedman M, et al. Establishing a registry for inflammatory bowel disease patients in maccabi healthcare services\u2014joint project between hospitals, Epi-Iirn Group and Community Medicine. Harefuah. 2018;157(10):655\u20139.","journal-title":"Harefuah"},{"issue":"9","key":"2087_CR13","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/00365521.2019.1660799","volume":"54","author":"JF Ludvigsson","year":"2019","unstructured":"Ludvigsson JF, Andersson M, Bengtsson J, Eberhardson M, Fagerberg UL, Grip O, et al. Swedish Inflammatory Bowel Disease Register (SWIBREG)\u2014a nationwide quality register. Scand J Gastroenterol. 2019;54(9):1089\u2013101.","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"2087_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","volume":"18","author":"RD Hays","year":"2009","unstructured":"Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009;18(7):873\u201380.","journal-title":"Qual Life Res"},{"key":"2087_CR15","doi-asserted-by":"crossref","unstructured":"Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407\u201315.","DOI":"10.1016\/0197-2456(89)90005-6"},{"issue":"2","key":"2087_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/0163278705275342","volume":"28","author":"SL Eremenco","year":"2005","unstructured":"Eremenco SL, Cella D, Arnold BJ. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof. 2005;28(2):212\u201332.","journal-title":"Eval Health Prof"},{"key":"2087_CR17","unstructured":"Israel Central Bureau of Statistics. Characterization and classification of geographic units by the socioeconomic level of the population 2008. Publication No. 1530. Jerusalem, Israel; 2013."},{"issue":"25","key":"2087_CR18","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083\u2013107.","journal-title":"Stat Med"},{"key":"2087_CR19","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, N.J.: L. Erlbaum Associates; 1988. xxi, 567 p."},{"key":"2087_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2310\/6640.2004.15377","volume":"56","author":"PW Stratford","year":"2004","unstructured":"Stratford PW. Getting more from the literature: Estimating the standard error of measurement from reliability studies. Physiother Can. 2004;56:27\u201330.","journal-title":"Physiother Can"},{"key":"2087_CR21","volume-title":"Is this change real? Interpreting patient outcomes in physical therapy","author":"DL Riddle","year":"2013","unstructured":"Riddle DL, Stratford PW. Is this change real? Interpreting patient outcomes in physical therapy. Philadelphia: F.A. Davis Co.; 2013."},{"issue":"12","key":"2087_CR22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.2519\/jospt.2019.8862","volume":"49","author":"D Deutscher","year":"2019","unstructured":"Deutscher D, Cook KF, Kallen MA, Werneke MW, Hayes D, Mioduski JE, et al. Clinical interpretation of the neck functional status computerized adaptive test. J Orthop Sports Phys Ther. 2019;49(12):875\u201386.","journal-title":"J Orthop Sports Phys Ther"},{"issue":"5","key":"2087_CR23","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126(5):1763\u20138.","journal-title":"Anesth Analg"},{"issue":"10","key":"2087_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223893","volume":"14","author":"AL Bathe","year":"2019","unstructured":"Bathe AL, Mavropoulou E, Mechie NC, Petzold G, Ellenrieder V, Kunsch S, et al. Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn\u2019s disease and ulcerative colitis. PLoS ONE. 2019;14(10): e0223893.","journal-title":"PLoS ONE"},{"issue":"3","key":"2087_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.crohns.2010.12.012","volume":"5","author":"I Blumenstein","year":"2011","unstructured":"Blumenstein I, Herrmann E, Filmann N, Zosel C, Tacke W, Bock H, et al. Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study. J Crohns Colitis. 2011;5(3):203\u201310.","journal-title":"J Crohns Colitis"},{"issue":"8","key":"2087_CR26","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/ibd\/izaa263","volume":"27","author":"G Chen","year":"2021","unstructured":"Chen G, Lissoos T, Dieyi C, Null KD. Development and validation of an inflammatory bowel disease severity index using US administrative claims data: a retrospective cohort study. Inflamm Bowel Dis. 2021;27(8):1177\u201383.","journal-title":"Inflamm Bowel Dis"},{"key":"2087_CR27","doi-asserted-by":"crossref","unstructured":"Greuter T, Manser C, Pittet V, Vavricka SR, Biedermann L, on behalf of Swiss Ibdnet aowgotSSoG. Gender differences in inflammatory bowel disease. digestion. 2020;101 Suppl 1:98\u2013104.","DOI":"10.1159\/000504701"},{"issue":"1","key":"2087_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ibd\/izz104","volume":"26","author":"KT Park","year":"2020","unstructured":"Park KT, Ehrlich OG, Allen JI, Meadows P, Szigethy EM, Henrichsen K, et al. The cost of inflammatory bowel disease: an initiative from the Crohn\u2019s & Colitis Foundation. Inflamm Bowel Dis. 2020;26(1):1\u201310.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"2087_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34\u201342.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"2087_CR30","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3109\/17453674.2010.537808","volume":"81","author":"KE Wamper","year":"2010","unstructured":"Wamper KE, Sierevelt IN, Poolman RW, Bhandari M, Haverkamp D. The Harris hip score: Do ceiling effects limit its usefulness in orthopedics? Acta Orthop. 2010;81(6):703\u20137.","journal-title":"Acta Orthop"},{"key":"2087_CR31","unstructured":"IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. Version 25.0 ed. Armonk, NY: IBM Corp."},{"key":"2087_CR32","unstructured":"StataCorp. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP2015."},{"key":"2087_CR33","doi-asserted-by":"crossref","unstructured":"Borowsky PA, Kadri OM, Meldau JE, Blanchett J, Makhni EC. The Remote Completion Rate of Electronic Patient-Reported Outcome Forms Before Scheduled Clinic Visits-A Proof-of-Concept Study Using Patient-Reported Outcome Measurement Information System Computer Adaptive Test Questionnaires. J Am Acad Orthop Surg Glob Res Rev. 2019;3(10).","DOI":"10.5435\/JAAOSGlobal-D-19-00038"},{"key":"2087_CR34","doi-asserted-by":"crossref","first-page":"205520761664484","DOI":"10.1177\/2055207616644844","volume":"2","author":"JS Howard","year":"2016","unstructured":"Howard JS, Toonstra JL, Meade AR, Whale Conley CE, Mattacola CG. Feasibility of conducting a web-based survey of patient-reported outcomes and rehabilitation progress. Digit Health. 2016;2:2055207616644844.","journal-title":"Digit Health"},{"issue":"6","key":"2087_CR35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3322\/caac.21573","volume":"69","author":"SM Licqurish","year":"2019","unstructured":"Licqurish SM, Cook OY, Pattuwage LP, Saunders C, Jefford M, Koczwara B, et al. Tools to facilitate communication during physician-patient consultations in cancer care: an overview of systematic reviews. CA Cancer J Clin. 2019;69(6):497\u2013520.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2087_CR36","doi-asserted-by":"publisher","DOI":"10.2196\/11373","volume":"4","author":"MM Karsten","year":"2018","unstructured":"Karsten MM, Speiser D, Hartmann C, Zeuschner N, Lippold K, Kiver V, et al. Web-based patient-reported outcomes using the international consortium for health outcome measurement dataset in a major German University Hospital: observational study. JMIR Cancer. 2018;4(2): e11373.","journal-title":"JMIR Cancer"},{"issue":"1","key":"2087_CR37","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12874-019-0859-9","volume":"19","author":"MM Millar","year":"2019","unstructured":"Millar MM, Elena JW, Gallicchio L, Edwards SL, Carter ME, Herget KA, et al. The feasibility of web surveys for obtaining patient-reported outcomes from cancer survivors: a randomized experiment comparing survey modes and brochure enclosures. BMC Med Res Methodol. 2019;19(1):208.","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"2087_CR38","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ajg.2015.120","volume":"110","author":"MH Mosli","year":"2015","unstructured":"Mosli MH, Zou G, Garg SK, Feagan SG, MacDonald JK, Chande N, et al. C-Reactive Protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(6):802\u201320.","journal-title":"Am J Gastroenterol."},{"issue":"6","key":"2087_CR39","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/jgh.14563","volume":"34","author":"J Burisch","year":"2019","unstructured":"Burisch J, Zammit SC, Ellul P, Turcan S, Duricova D, Bortlik M, et al. Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: an Epi-IBD study. J Gastroenterol Hepatol. 2019;34(6):996\u20131003.","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-023-02087-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-023-02087-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-023-02087-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T12:07:33Z","timestamp":1673611653000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-023-02087-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2087"],"URL":"https:\/\/doi.org\/10.1186\/s12955-023-02087-0","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"assertion":[{"value":"20 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The MHS research committee and the institutional review board approved the study (IRB#: 0103-18-BBL) and provided an exempt status from the need to complete a formal consent form as described above.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. The manuscript, including related data, figures and tables, has not been previously published and is not under consideration elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This project was supported by an institutional grant from Takeda Pharmaceutics to Maccabi Healthcare Services and did not include the medical writing by the Maccabi authors. Tsukinovsky is an employee of Takeda Pharmaceuticals. Takeda\u2019s employees do not have any stock or stock options. Deutscher, Weil, and Chodick do not have any conflicts of interest. Waterman and Kariv provide consultation for Takeda Pharmaceutics, Petach Tikva, Israel. All authors declare they have no other financial or conflicts of interests related to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}